<p>Based on a minimum tumour purity of 30%, the sensitivity for SNVs and INDELs is 96% and 89%, respectively. The sensitivity for CNVs and RNA fusions is 86% and 32%, respectively. The limit of detection is 10% VAF for SNVs and 20% for INDELs.</p>
<p>This test was developed and its performance characteristics determined by OICR Genomics. It has not been cleared or approved by the US Food and Drug Administration.</p>